Full-Time

Medical Director

Vascular Malformations

Posted on 11/19/2024

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD, MD/PhD or other advanced degree with 5+ years of clinical development experience in academic and/or industry settings.
  • Candidates trained in pediatric hematology/oncology and/or clinical or industry experience with adult and pediatric patients with vascular malformations are preferred.
  • Exposure to design and execution of clinical trials; protocol development and design, development of case report forms, and statistical analysis plans.
  • Exposure to working closely with investigative sites, including principal investigators, sub-investigators, study coordinators, and other site personnel involved in clinical trials.
  • Excellent written and oral communication skills.
Responsibilities
  • Collaborate with senior medical staff, drug discovery teams, translational medicine, clinical operations, clinical investigators and disease-specific experts to design and execute early clinical development plans that definitively test key translational hypotheses for Relay Tx medicines and establish clinical proof-of-concept as soon as possible after entering human testing.
  • Write clinical sections of key documents, including Investigator’s Brochures, IND summary documents, CTAs for initiation of ex-US studies and work with senior medical staff for responses to questions from regulatory authorities, IRBs, and ethics committees.
  • Provide expert medical review, assessment, and interpretation of clinical data and prepare results for presentation to internal clinical development leadership and external stakeholder including regulatory authorities.
  • Manage drug safety and pharmacovigilance activities for ongoing trial(s).
  • Attend and support clinical site initiation visits.
  • Rapidly integrate new insights derived from on-going Relay Tx or external clinical trials, translational science or basic science into Relay Tx development plans and clinical trial activities.
  • Collaborate with research leadership and drug discovery teams to shape the Relay Tx drug discovery portfolio.
  • Proactively manage communication and build strong collaborative relationships with key stakeholders.
  • Ensure Relay Tx maintains the highest standards of compliance and ethical behavior in the design, conduct, interpretation and communication of clinical trials, clinical trial data, and clinical trial results.

Relay Therapeutics focuses on drug discovery by studying protein motion to develop new treatments for complex diseases. Their main tool, the Dynamo™ platform, uses both experimental and computational methods to identify potential drug candidates, especially for hard-to-target proteins. This approach allows them to explore new treatment options in areas like precision oncology and genetic diseases. Unlike other companies, Relay Therapeutics emphasizes the importance of protein dynamics in their research, which sets them apart in the biotech field. Their goal is to create effective medicines that can significantly improve patients' lives, and they are currently conducting clinical trials to ensure the safety and effectiveness of their drug candidates.

Company Stage

IPO

Total Funding

$535M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-12%

2 year growth

-8%
Simplify Jobs

Simplify's Take

What believers are saying

  • Relay's focus on precision oncology and genetic diseases positions it at the forefront of personalized medicine, offering significant growth potential.
  • Recent investments and financing, including a $30 million private placement and $400 million Series C financing, indicate strong financial backing and investor confidence.
  • Initial clinical data for RLY-2608 and other promising drug candidates highlight the company's potential for successful therapeutic developments.

What critics are saying

  • The highly competitive biotech sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and licensing agreements could pose risks if collaborations do not yield expected results.

What makes Relay Therapeutics unique

  • Relay Therapeutics places protein motion at the core of its drug discovery process, a unique approach that sets it apart from traditional methods.
  • The Dynamo™ platform combines experimental and computational techniques to target previously undruggable proteins, expanding treatment possibilities.
  • Strategic collaborations, such as the one with Genentech, validate the potential of Relay's innovative technology and approach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO